bioRxivNeurosciencePreprint
Prodromal pathogenesis of CLN7 Batten Disease revealed by multimodal biomarkers in macaques
William A. LiguoreiD, Winde Hilven, Lili LuryeiD, Jordy AkkermansiD, Marion DecropiD, Robert C. Zweig, Larry S. ShermaniD, Jodi L. McBrideiD, Daniele BertoglioiD, Alison R. WeissiD
Abstract
Neuronal ceroid lipofuscinosis type 7 (CLN7) is a devastating paediatric neurodegenerative disorder with no cure and limited natural history data to guide therapeutic development. Here, we present the first multimodal characterization of prodromal and early-stage CLN7 disease in Japanese macaques carrying a spontaneous CLN7-/- mutation. Using structural T2-weighted MRI for volumetry, [18F]FDG PET for glucose metabolism, and [11C]PBR28 PET for neuroinflammation, we observed region-dependent patterns in volumetric, molecular, and metabolic alterations. MRI confirmed the presence of disease-associated atrophy in many cortical and subcortical brain regions, consistent with human pathology, [18F]FDG PET revealed early cortical and subcortical widespread hypometabolism, and [11C]PBR28 PET imaging detected progressive neuroinflammation in the same brain areas. CSF analyses further showed age-dependent increases in neurofilament light (NfL), providing convergent evidence for neurodegeneration. Together, these results define a prodromal trajectory in CLN7 disease, establish sensitive imaging and fluid biomarkers, and validate the macaque model as a powerful platform for testing interventions.
- organism: non-human primate
- assay: imaging
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondrial collapse links PFKFB3-promoted glycolysis with CLN7/MFSD8 neuronal ceroid lipofuscinosis pathogenesis
Irene López-Fabuel, Marina García Macia, … Juan Pedro Bolaños·bioRxiv·Oct 20, 2020
- CLN7 mutation causes aberrant redistribution of protein isoforms and contributes to Batten disease pathobiology
A. Sharaireh, M. Guevara Ferrer, … T. R. McKay·bioRxiv·Apr 21, 2022
- CLN3 deficiency leads to neurological and metabolic perturbations during early development
Ursula Heins-Marroquin, Randolph R. Singh, … Carole L. Linster·Life Science AlliancePeer-reviewed·Jan 9, 2024
- Reduction of Neuroinflammation and Seizures in a Mouse Model of CLN1 Batten Disease using the Small Molecule Enzyme Mimetic, N-Tert-Butyl Hydroxylamine.
Zach Fyke, Rachel Johansson, … Akira Yoshii·Molecular Genetics and MetabolismPeer-reviewed·Jul 15, 2024
- Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease
Sophia-Martha kleine Holthaus, Saúl Herranz-Martín, … Robin R. Ali·Human Molecular GeneticsPeer-reviewed·Aug 28, 2019
- A multimodal approach to identify clinically relevant parameters to monitor disease progression in a preclinical model of neuropediatric disease
T. B. Johnson, J. J. Brudvig, … J. M. Weimer·bioRxiv·Jan 17, 2019